Disparity in Race-Specific Comorbidities Associated With Central Venous Catheter-Related Bloodstream Infection (AHRQ-PSI7)

American Journal of Medical Quality

Volumn 28, Issue 6, 2013, Pages 525-532

  Studnicki, James ^a   Ekezue, Bola F ^a   Tsulukidze, Maka ^a   Honoré, Peggy ^b   Moonesinghe, Ramal ^c   Fisher, John ^a  

^a UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^b U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

comorbidities; patient safety; racial disparity

Indexed keywords

AFRICAN AMERICAN; ARTICLE; CATHETER INFECTION; CAUCASIAN; CENTRAL VENOUS CATHETERIZATION; COMORBIDITIES; COMORBIDITY; CROSS-SECTIONAL STUDY; ETHNOLOGY; FEMALE; HEALTH CARE QUALITY; HEALTH DISPARITY; HUMAN; MALE; MIDDLE AGED; PATIENT SAFETY; POPULATION GROUP; RACIAL DISPARITY; RETROSPECTIVE STUDY; UNITED STATES;

COMORBIDITIES; PATIENT SAFETY; RACIAL DISPARITY;

AFRICAN AMERICANS; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; COMORBIDITY; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FLORIDA; HEALTH STATUS DISPARITIES; HUMANS; MALE; MIDDLE AGED; PATIENT SAFETY; POPULATION GROUPS; QUALITY INDICATORS, HEALTH CARE; RETROSPECTIVE STUDIES;

EID: 84887575000     PISSN: 10628606     EISSN: 1555824X     Source Type: Journal    
DOI: 10.1177/1062860613480826     Document Type: Article

References (32)

1. Agency for Healthcare Research and Quality. Quality indicator user guide: Patient Safety Indicators (PSI) composite measures. Version 4.4. http://www.qualityindicators.ahrq.gov/Downloads/Modules/PSI/V44/Composite_User_Technical_Specification_PSI%20V4.4.pdf. Accessed June 25, 2012.
2. Kaafarani HM,Rosen AK.Using administrative data to identify surgical adverse events: an introduction to the patient safety indicators.Am J Surg. 2009;198:S63-S68.
3. Miller MR,Elixhauser A,Zhan C,Meyer GS.Patient safety indicators: using administrative data to identify potential patient safety concerns.Health Serv Res. 2001;36 (6, pt 2): 110-132.
4. Naessens JM,Campbell CR,Shah N,et al.Effect of illness severity and comorbidity on patient safety and adverse events.Am J Med Qual. 2012;27:48-57.
5. Rivard PE,Luther SL,Christiansen CL,et al.Using patient safety indicators to estimate the impact of potential adverse events on outcomes.Med Care Res Rev. 2008;65:67-87.
6. Romano PS,Geppert JJ,Davies S,Miller MR,Elixhauser A,McDonald KM.A national profile of patient safety in US hospitals.Health Aff (Millwood). 2003;22:154-166.
7. Rosen AK,Zhao S,Rivard P,et al.Tracking rates of patient safety indicators over time: lessons from the Veterans Administration.Med Care. 2006;44:850-861.
8. Coffey RM,Andrews RM,Moy E,et al.Racial, ethnic, and socioeconomic disparities in estimates of AHRQ patient safety indicators.Med Care. 2005;43:I48-I57.
9. Metersky ML,Hunt DR,Kliman R,et al.Racial disparities in the frequency of patient safety events: results from the National Medicare Patient Safety Monitoring System.Med Care. 2011;49:504-510.
10. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academies Press; 2003.
11. Fry DE,Pine M,Jones BL,Meimban RJ.Patient characteristics and the occurrence of never events.Arch Surg. 2010;145:148-151.
12. Will JC,Valderrama AL,Yoon PW.Preventable hospitalizations for congestive heart failure: establishing a baseline to monitor trends and disparities.Prev Chronic Dis. 2012;9:E85.
13. Agency for Healthcare Research and Quality. Diabetes disparities among racial and ethnic minorities. http://www.ahrq.gov/research/diabdisp.htm. Accessed July 26, 2012.
14. Esper AM,Moss M,Lewis CA,Nisbet R,Mannino DM,Martin GS.The role of infection and comorbidity: factors that influence disparities in sepsis.Crit Care Med. 2006;34:2576-2582.
15. Hasnain-Wynia R,Baker DW,Nerenz D,et al.Disparities in health care are driven by where minority patients seek care: examination of the hospital quality alliance measures.Arch Intern Med. 2007;167:1233-1239.
16. Pippins JR,Fitzmaurice GM,Haas JS.Hospital characteristics and racial disparities in hospital mortality from common medical conditions.J Natl Med Assoc. 2007 1030;99.
17. Vartak S,Ward MM,Vaughn TE.Do postoperative complications vary by hospital teaching status?.Med Care. 2008;46:25-32.
18. Jha AK,Staiger DO,Lucas FL,Chandra A.Do race-specific models explain disparities in treatments after acute myocardial infarction?.Am Heart J. 2007;153:785-791.
19. Yu H,Greenberg MD,Haviland AM,Farley DO."Canary measures" among the AHRQ patient safety indicators.Am J Med Qual. 2009;24:465-473.
20. Agency for Healthcare Research and Quality. PSI #7 Central venous catheter-related bloodstream infections. http://www.qualityindicators.ahrq.gov/Downloads/Modules/PSI/V41/TechSpecs/PSI%2007%20Central%20Venous%20Catheter-related%20Bloodstream%20Infections.pdf. Accessed May 9, 2012.
21. Agency for Healthcare Research and Quality. Patient Safety Indicators: software documentation. Version 4.2. http://www.qualityindicators.ahrq.gov/Downloads/Software/SAS/V42/psi_sas_documentation_v42.pdf. Accessed July 12, 2012.
22. Elixhauser A,Steiner C,Harris DR,Coffey RM.Comorbidity measures for use with administrative data.Med Care. 1998;36:8-27.
23. Barnett AG,Beyersmann J,Allignol A,Rosenthal VD,Graves N,Wolkewitz M.The time-dependent bias and its effect on extra length of stay due to nosocomial infection.Value Health. 2011;14:381-386.
24. Forster AJ,Taljaard M,Oake N,Wilson K,Roth V,van Walraven C.The effect of hospital-acquired infection with Clostridium difficile on length of stay in hospital.CMAJ. 2012;184:37-42.
25. Gaskin DJ,Spencer CS,Richard P,Anderson GF,Powe NR,LaVeist TA.Do hospitals provide lower-quality care to minorities than to whites?.Health Affairs (Millwood). 2008;27:518-527.
26. Shroff GR,Taylor AL,Colvin-Adams M.Race-related differences in heart failure therapies: simply black and white or shades of grey?.Curr Cardiol Rep. 2007;9:178-181.
27. Carson P,Ziesche S,Johnson G,Cohn JN.Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group.J Card Fail. 1999;5:178-187.
28. Yancy CW.Heart failure in African Americans: a cardiovascular engima.J Card Fail. 2000;6:183-186.
29. Taylor AL,Wright JT.Should ethnicity serve as the basis for clinical trial design? Importance of race/ethnicity in clinical trials: lessons from the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).Circulation. 2005;112:3654 3666-3660.
30. Mathew J,Wittes J,McSherry F,et al.Racial differences in outcome and treatment effect in congestive heart failure.Am Heart J. 2005;150:968-976.
31. Bales CW,Ritchie CS.Sarcopenia, weight loss, and nutritional frailty in the elderly.Annu Rev Nutr. 2002;22:309-323.
32. Marton KI,Sox HC,Krupp JR,et al.Involuntary weight loss: diagnostic and prognostic significance.Ann Intern Med. 1981;95:568-574.